Analysis by Location (Malls, Retail Stores, and Others); by Ownership (Hospitals, Retail, and Others); and by Application (Clinical Chemistry & Immunoassay, Point-of-Care Diagnostics, Vaccinations, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Buy Now
The global retail clinics market is estimated to garner a revenue of ~ USD 8 Billion by the end of 2033 by growing at a CAGR of ~14% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~ USD 4 Billion in the year 2022. he growth of the market is primarily ascribed to the increasing role of retail clinics by providing convenience in treating minor illness, preventive health screenings, and a good alternative for expensive emergency care for minor health conditions. For instance, up to 21% of visits to emergency rooms for non-emergencies are estimated to be preventable if they were made at retail clinics or urgent care centers, that result in yearly cost savings of up to USD 4 billion.
Get more information on this report:Request Sample PDF
Since the start of pandemic to the post pandemic period, the burden on other conventional healthcare institutions has increased a lot. In such scenario, the role of retail clinics has emerged as a boon and more advantageous to deal with those health issues which are easy to diagnose and treat. According to the World Health Organization (WHO), In Africa region, there are only about two medical doctors for every 10,000 people, while there are only ten nurses and midwives for every 10,000 people. Furthermore, nearly 18 million more healthcare workers are required in low and lower-middle income nations.
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~14% |
|
Base Year Market Size (2022) |
~ USD 4 Billion |
|
Forecast Year Market Size (2033) |
~ USD 8 Billion |
|
Regional Scope |
|
Growth Drivers
Increase in Strep Throat Cases - Strep throat is a bacterial infection that leads to throat swelling and pain. The bacteria in group A Streptococcus end up causing this common condition. Children and adults of all ages get strep throat. However, it is especially common among children aged 5 to 15. Therefore, increasing cases of strep throat is one of the leading factors for the growth of retail clinics market. For instance, every year, approximately 610 million people globally contract strep throat, with many of them are children.
Global Upsurge in Urinary Tract Infection - Globally, there are anticipated to be 152 million UTI infection cases annually, costing more than USD 6.5 billion in direct medical expenses.
Staggering Increase in COVID-19 Detection Tests - Austria had conducted the most COVID-19 tests per 1 million population among the countries which are most seriously affected by the pandemic as of September 12, 2022. Whereas, the United States has administered nearly over 1 billion COVID-19 tests in total.
Rise in Urbanization – As per the World Bank, currently, more than 50% of the world's population resides in cities. The number of people living in urban areas is estimated to rise more than double to 6 billion by 2045.
Escalation of Retail Clinics for Immunization – According to the Centers for Disease Control and Prevention, more than 266.5 million doses of the COVID-19 vaccine had been given and recorded by Federal Retail Pharmacy Program participants in the US as of September 15, 2022. This comprises are the 8 million doses given on-site to long-term care facilities. With more than 41,000 sites nationwide, the program has a total of 21 retail pharmacy partners.
Challenges
The global retail clinics market is segmented and analyzed for demand and supply by application into clinical chemistry & immunoassay, point-of-care diagnostics, vaccinations, and others. Out of these, the point-of-care diagnostics segment is estimated to garner the largest market size over the forecast period owing to the worldwide growing prevalence of various lifestyle disorders such as obesity, diabetes, hypertension, and other disorders. For instance, as per research, the total number of diabetes patients is estimated to upsurge to 641 million by 2030 and 786 million by 2045.
The North America retail clinics market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033, backed by the existence of key retail clinic providers, growing geriatric population, increasing prevalence of sinusitis infections, and sufficient insurance coverage provided by these retail clinics in the region. According to the Centers for Disease Control and Prevention, till 2022, the number of adults diagnosed with sinusitis in the United States have risen to 28.9 million.
Our in-depth analysis of the global retail clinics market includes the following segments:
|
By Location |
|
|
By Ownership |
|
|
By Application |
|
The Kroger Co.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Ans: Increase in strep throat cases, global upsurge in urinary tract infection, staggering increase in covid-19 detection tests, and rise in urbanization are some major factors driving the growth of the market.
Ans: The market is anticipated to attain a CAGR of ~14% over the forecast period, i.e., 2023 – 2033.
Ans: Insufficient infrastructure for retail clinics, inadequacy of provision for treating complex diseases, and stringent governmental regulations are estimated to hamper the market growth.
Ans: The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
Ans: The major players in the market are The Kroger Co., CVS Health Corporation, Walmart Inc., Walgreen Co., Bellin Health, Concentra, Inc., MedExpress, Advocate Health Care, and others.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by location, ownership, application, and by region.
Ans: The point-of-care diagnostics segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
